4//SEC Filing
Anglin Robert M 4
Accession 0001209191-09-006915
CIK 0000868368other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:14 PM ET
Size
12.7 KB
Accession
0001209191-09-006915
Insider Transaction Report
Form 4
Anglin Robert M
VP Quality & Regulatory
Transactions
- Award
Stock Option (Right to Buy)
2009-02-03+20,000→ 20,000 totalExercise: $11.27From: 2010-02-03Exp: 2019-02-03→ Common Stock (20,000 underlying)
Holdings
- 8,000
Stock Option (Right to Buy)
Exercise: $2.17Exp: 2011-10-16→ Common Stock (8,000 underlying) - 4,000
Stock Option (Right to Buy)
Exercise: $4.63Exp: 2014-01-02→ Common Stock (4,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $11.91From: 2007-11-29Exp: 2016-11-29→ Common Stock (10,000 underlying) - 5,000
Stock Option (Right to Buy)
Exercise: $10.89From: 2009-02-12Exp: 2018-02-12→ Common Stock (5,000 underlying) - 600
Common Stock
- 10,000
Stock Option (Right to Buy)
Exercise: $2.34Exp: 2011-04-06→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Currently 100% vested.
- [F2]Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown.
Documents
Issuer
ROCHESTER MEDICAL CORPORATION
CIK 0000868368
Entity typeother
Related Parties
1- filerCIK 0001450690
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:14 PM ET
- Size
- 12.7 KB